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Abstract:	   	  
We	   present	   a	   rare	   case	   of	   a	   23-­‐year-­‐old	   male	   incidentally	   detected	   with	   hepatitis	   B	   virus	   (HBV)	  
infection	   presenting	   with	   features	   suggestive	   of	   HBV-­‐associated	   nephropathy.	   A	   renal	   biopsy	  
specimen	   suggested	   a	   mesangioproliferative	   glomerulonephritis	   with	   a	   full-­‐house	   pattern	   on	  
immunoflourescence	  consistent	  with	  a	  diagnosis	  of	  diffuse	   lupus	  nephritis.	  Glomerular	  HbeAg	  and	  
HbsAg	   antigens	   were	   not	   detectable	   by	   immunofluorescence.	   Antiviral	   therapy	   was	   instituted	   to	  
suppress	  viral	  replication,	  thereby	  leading	  to	  clinical	  and	  virological	  remission,	   including	  that	  of	  the	  
glomerulonephritis,	  without	  the	  need	  for	  additional	   immunosuppressant	  therapy.	  This	  case	  depicts	  
the	   uniqueness	   of	   the	   presentation	   of	   the	   two	   conditions	   mimicking	   each	   other,	   the	   strategy	  
adopted	  to	  prevent	  the	  activation	  of	  viral	  replication	  and	  the	  achievement	  of	  clinical	  remission.	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Introduction	  
One	  of	  the	  important	  extrahepatic	  manifestations	  of	  hepatitis	  B	  virus	  (HBV)	  infection	  is	  the	  evolution	  
of	  HBV-­‐associated	  nephropathy,	  mediated	  mostly	  by	   immune	   complex	  deposition.	  HBV-­‐associated	  
membranous	   glomerulonephritis	   and	   grade	   V	   lupus	   membranous	   nephritis	   can	   at	   times	   be	  
morphologically	   indistinct,	  with	  no	  single	  or	  combined	  features	  carrying	  a	  positive	  predictive	  value	  
for	   their	   individual	   diagnosis.	   This	   is	   primarily	   because	   both	   can	   present	   as	   an	   immune	   complex–
mediated	  glomerulopathy	  with	  a	  diffuse	  proliferative	  pattern	  of	  injury	  and	  a	  “full-­‐house”	  pattern	  on	  
immunoflourescence	   [1].	   Only	   the	   detection	   of	   viral	   antigens	   in	   glomeruli	   by	   the	   use	   of	   specific	  
monoclonal	  antisera	  can	  link	  the	  virus	  with	  glomerular	  lesions	  [1].	  Although	  as	  yet	  no	  clearly	  causal	  
relationship	   has	   been	   established	   between	   HBV	   and	   lupus	   nephritis,	   this	   association	   cannot	   be	  
termed	  merely	  as	  coincidental	  since	  immune	  complex	  deposition	  in	  lupus	  nephritis	  can	  be	  triggered	  
by	   HBV.	   This	   also	   resulted	   in	   a	   dilemma	   in	   the	   management	   regarding	   whether	   antiviral	   or	  
immunosuppressive	  therapy	  should	  be	  initiated	  first,	  as	  both	  disease	  components	  are	  critical	  for	  the	  
long-­‐term	  prognosis	  of	  the	  patient.	   	  
	  
Case	  report	   	  
A	  23-­‐year-­‐old	  male	  of	  south	  Asian	  ethnicity	  presented	  with	  complaints	  of	  generalised	  body	  swelling	  
for	  four	  months,	  abdominal	  pain	  with	  progressively	  increasing	  abdominal	  distension	  for	  one	  month	  
and	   low-­‐grade	   fever.	   There	  was	   no	   history	   of	   oliguria,	   dyspnoea,	   chest	   pain,	   haematuria,	   dysuria,	  
loss	   of	  weight	   or	   appetite,	   rashes,	   joint	   pain,	   neuropsychiatric	   symptoms	  or	   altered	  bowel	   habits.	  
There	  was	  a	  significant	  past	  history	  of	  jaundice	  two	  years	  earlier	  that	  had	  resolved	  on	  its	  own	  in	  two	  
months.	  There	  was	  no	  contributory	  family	  history	  of	  hypertension,	  diabetes	  mellitus,	  coronary	  artery	  
disease,	  chronic	  kidney	  disease	  or	  similar	  illness.	   	  
On	  presentation,	  the	  patient	  was	  normotensive	  and	  mildly	  anaemic,	  with	  bilateral	  symmetrical	  pedal	  
oedema.	  Chest	  examination	  revealed	  the	  presence	  of	  minimal	  bilateral	  pleural	  effusion,	  which	  was	  
confirmed	  on	  chest	  X-­‐ray.	   	  
Investigations	   on	   presentation	   revealed	   pancytopenia	   (Hb	   9.0	   g/dl,	   total	   leukocyte	   count	   2900/µl,	  
platelet	   count	   45,000/µl),	   raised	   ESR	   of	   72	   mm	   in	   one	   hour,	   hypoalbuminaemia	   1.8	   g/dl	   and	   an	  
albumin:globulin	   ratio	   reversal	   (0.62).	   Liver	   function	   tests	   (LFT)	   initially	   showed	   mild	  
hyperbilirubinaemia	   (1.8	  mg/dl)	  with	   alanine	   transaminase	   (ALT)	   levels	   approximately	   three	   times	  
above	   normal	   (110	   U/l),	   which	   resolved	   in	   due	   course.	   The	   coagulation	   profile	   remained	   within	  
normal	  limits	  (INR	  1.00).	  Kidney	  function	  tests	  remained	  normal	  throughout	  the	  course	  of	  the	  illness.	  
C-­‐reactive	  protein	   (CRP)	  was	   found	   to	  be	  negative	   (<6.0	  mg/dl),	  with	  a	  negative	  Mantoux	   test	   (03	  
mm).	  C3	  levels	  were	  found	  to	  be	  decreased	  to	  0.34	  g/l	  (normal	  range	  0.9–1.8).	  Anti-­‐nuclear	  antibody	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be	  negative.	  HIV	  and	  anti-­‐HCV	  were	  negative.	  
The	  patient	  was	  put	  on	  enalapril	  (5	  mg/day)	  and	  furosemide	  (40	  mg	  twice	  a	  day).	  Hepatitis	  B	  surface	  
antigen	  (HbsAg)	  was	  found	  to	  be	  positive.	   	  
HBV	   DNA	   titre	  was	   1×106	  copies/ml,	   hepatitis-­‐B	   ‘e’	   antigen	   (HbeAg)	  was	   positive,	   and	   anti-­‐HbeAg	  
antibody	   was	   negative.	   Urine	   evaluation	   showed	  moderate	   proteinuria	   (24-­‐h	   urinary	   protein	   was	  
1872	  mg).	   	  
Abdominal	  ultrasound	  showed	  coarse	  liver	  
echo	   texture,	   splenomegaly	  with	  multiple	  
portosystemic	  collaterals	  and	  normal-­‐sized	  
kidneys	   with	   well	   maintained	  
corticomedullary	  differentiation.	  
On	   renal	   biopsy	   	   (Fig.	   1a–d),	  
immunoflourescence	   showed	   a	  
‘full-­‐house’	   pattern	   with	   deposition	   of	  
immunoglobulin	   G,M,A	   (IgG)	   and	  
complements	  C3	  and	  C1q.	  (Fig.	  2a–d).	   	  
In	   view	   of	   the	   serological	   investigations	  
and	   immunofluorescence	   findings,	   a	  
diagnosis	  of	  diffuse	  lupus	  nephritis	  Class	  IV	  
(ISN/RPS	   classification)	   was	   made.	  
Glomerular	   deposition	   of	   HbeAg	   and	  
HbsAg	   could	   not	   be	   demonstrated	   by	  
immunohistochemistry.	   The	   patient’s	  
anasarca	   responded	   to	   medical	   therapy.	  
Immunosuppressants	   were	   withheld	   for	  
fear	   of	   hepatic	   decompensation	   due	   to	  
flaring	  up	  of	  hepatitis	  B	  infection.	   	  
The	  patient	  was	  subsequently	  put	  on	  0.5	  
mg	   of	   entecavir	   0.5	   mg	   once	   daily.	   The	  
patient	   is	   currently	   in	   clinical	   and	  
virological	  sustained	  remission	  (HBV	  DNA	  
titre:	   100	   copies/ml).	   Following	   the	  
antiviral	   therapy,	   the	   proteinuria	  
remarkably	   reduced	   to	   200	   mg/day.	   A	  
clinical	   diagnosis	   of	   chronic	   active	  
hepatitis	   B	   with	   HBV-­‐associated	  
Figure	  1:	  Light	  microscopy	  photomicrographs.	  (a,b)	  Haematoxylin	  and	  
eosin	   (HE)-­‐stained	   sections	  of	   kidney	  biopsy	  at	   low-­‐	  and	  high-­‐power	  
view	  showing	  enlarged	  glomeruli	  displaying	  an	  increase	  in	  mesangial	  
matrix	   and	   cellularity	   (magnification	   100×	   and	   200×,	  
respectively).(c,d)	   Periodic	   acid	  Schiff	   (PAS)-­‐	   and	  silver	  methenamine	  
(Sm)-­‐stained	   sections	   of	   kidney	   biopsy	   at	   high	   power	   displaying	  
splitting	  of	  basement	  membranes	  (magnification	  400×).	  
Figure	  2:	  Immunofluorescence	  photomicrographs.	  (a–d)	  Frozen	  sections	  
of	   kidney	   biopsy	   stained	   with	   IgG,	   C3,	   IgM	   and	   C1q,	   respectively,	  
displaying	   immune	   complex	   and	   complement	   deposition	   along	   the	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glomerulonephritis	  was	  made.	  
	  
Discussion	  
The	  uniqueness	  of	  our	  case	  was	  the	  initial	  discovery	  of	  chronic	  active	  hepatitis	  B	  along	  with	  nephritis	  
histologically	   resembling	   diffuse	   lupus	   nephritis	   despite	   normal	   kidney	   function	   tests	   and	   the	  
absence	  of	  clinical	  hepatic	  deterioration.	   	  
Impaired	  production	  of	   interferon	   in	   peripheral	   blood	  mononuclear	   cells	   has	   been	   reported	   to	  be	  
potentially	  pathogenic	   to	  both	  chronic	  HBV	   infection	  and	  systemic	   lupus	  erythematosus	   (SLE).	  The	  
immunoflourescence	  examination	  shows	  that	  although	  the	  deposition	  of	  C3	  and	  C1q	  is	  more	  frequent	  
in	   HBV	  membranous	   glomerulonephritis	   as	   compared	   to	   membranous	   glomerulonephritis	   due	   to	  
other	   secondary	  causes,	  a	   ‘full-­‐house’	  pattern	   is	  not	  very	   common	   [2].	  Previous	  experiments	  have	  
suggested	   that	   initiation	   of	   immune-­‐tolerant	   therapy	   in	   the	   form	   of	   interferon-­‐α	   has	   precipitated	  
severe	  SLE	  forms	  in	  patients	  being	  treated	  for	  HCV	  or	  HBV	  with	  or	  without	  coexisting	  HIV	  infection	  
[3].	   Therefore,	   immunosuppressant	   therapy	   for	   lupus	   risks	   exacerbating	   underlying	   infection	   in	  
patients	  with	   concurrent	   HIV,	   HBV	   or	   HCV	   by	   reactivating	   the	   viral	   replication	   in	   the	   presence	   of	  
decreased	  immunity,	  which	  can	  be	  very	  detrimental	  [4].	   	  
There	   is	   some	   uncertainty	   as	   to	   how	   to	   manage	   nephritis	   and	   chronic	   active	   hepatitis	   B	  
simultaneously,	  but	  our	  approach	  of	  targeting	  the	  hepatitis	  first	  seems	  to	  have	  been	  very	  effective.	  
Corticosteroids	   given	   at	   the	   onset	   of	   nephrotic	   syndrome	   in	   HBV	   membranous	   nephropathy	  
(HBVMN)	  do	  not	  seem	  to	  have	  an	  ameliorative	  effect	  on	  the	  nephrotic	  state	  or	  viral	  clearance	  [5].	  
On	  the	  contrary,	  serological	  evidence	  of	  active	  viral	  replication	  and	  histological	  deterioration	  did	  not	  
support	   the	   protective	   value	   of	   steroids	   in	   HBVMN.	   More	   recently,	   Tse	   et	   al.	   recommended	  
lamivudine	  treatment	  for	  virological	  flares	  in	  managing	  chronic	  hepatitis	  B	  patients	  with	  a	  history	  of	  
lupus	   nephritis	   [6].	   We	   therefore	   initiated	   antiviral	   therapy	   in	   the	   form	   of	   entecavir	   to	   achieve	  
virological	  remission	  instead	  of	  immunosuppressive	  therapy	  for	  the	  management	  of	  lupus	  nephritis.	  
	  
Conlcusion	  
This	  case	  report	   illustrates	  the	  complex	  interactions	  between	  HBV,	  SLE	  and	  antiviral	   immunity.	  The	  
risks	   of	   viral	   reactivation	   after	   initiation	   of	   immunosuppressive	   therapy	   for	   treatment	   of	  
autoimmune	   diseases	   like	   SLE	   need	   careful	   assessment	   and	   monitoring.	   Immunosuppressant	  
therapy	   is	   a	   double-­‐edged	   sword	   in	   this	   setting	   and	   therefore	   its	   benefits	   need	   to	   be	   balanced	  
against	   its	   hazards.	   Therefore,	   in	   the	   absence	   of	   detection	   of	   hepatitis	   antigens	   in	   glomeruli,	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Learning	  Points	  
• HBV-­‐associated	  membranous	  glomerulonephritis	  and	  grade	  V	  lupus	  membranous	  nephritis	  can	  
at	   times	  be	  morphologically	   indistinct	  with	  no	  single	  or	  combined	   features	  carrying	  a	  positive	  
predictive	  value	  for	  their	  individual	  diagnosis.	   	  
• There	   is	   uncertainty	   in	   management	   as	   to	   whether	   to	   first	   initiate	   antiviral	   or	  
immunosuppressive	   therapy,	   as	   both	   the	   disease	   components	   are	   critical	   for	   the	   long-­‐term	  
prognosis	  of	  the	  patient.	   	  
• It	   is	   currently	   recommended	   to	   initiate	   antiviral	   therapy	   for	   hepatitis	   to	   achieve	   virological	  
remission	   instead	   of	   immunosuppressive	   therapy	   for	   the	  management	   of	   lupus	   nephritis	   for	  
virological	  flares	  in	  chronic	  hepatitis	  B	  patients	  with	  a	  history	  of	  lupus	  nephritis.	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